Skip to main content
PLOS Global Public Health logoLink to PLOS Global Public Health
. 2024 Mar 11;4(3):e0002971. doi: 10.1371/journal.pgph.0002971

Factors associated with uptake of breast and cervical cancer screening among Nepalese women: Evidence from Nepal Demographic and Health Survey 2022

Bipul Lamichhane 1,*,#, Bikram Adhikari 1,#, Lisasha Poudel 2, Achyut Raj Pandey 1, Sampurna Kakchhapati 1, Saugat Pratap K C 1, Santosh Giri 1, Bishnu Prasad Dulal 1, Deepak Joshi 1, Ghanshyam Gautam 1, Sushil Chandra Baral 1
Editor: Prabhdeep Kaur3
PMCID: PMC10927089  PMID: 38466682

Abstract

Breast cancer screening (BCS) and cervical cancer screening (CCS) are integral parts of initiatives to reduce the burden associated with these diseases. In this context, we aimed to determine factors associated with BCS and CCS uptake among Nepalese women aged 30 to 49 years using data from the Nepal Demographic Health Survey (NDHS) 2022. We performed a weighted analysis to account complex survey design of the NDHS 2022. We employed univariable and multivariable logistic regression to determine factors associated with the uptake of BCS and CCS and results were presented as crude odds ratio and adjusted odds ratio (AOR) along with 95% confidence interval (CI). The uptake of BCS and CCS among Nepalese women aged 30 to 49 years were 6.5% and 11.4% respectively. Women from Terai compared to mountain region (AOR = 0.54, 95%CI: 0.31, 0.93) and those engaged in agriculture compared to non-working (AOR = 0.59, 95%CI: 0.42, 0.82) women had lower odds of BCS uptake. Conversely, Dalit women compared to Brahmin/Chhetri (AOR = 2.08, 95%CI: 1.37, 3.16), and women with basic (AOR = 1.49, 95%CI: 1.04, 2.13), secondary (AOR = 1.96, 95%CI: 1.33, 2.88), and higher education (AOR = 2.80, 95% CI: 1.51, 5.19) compared to those with no education had higher odds of BCS uptake. Women from rural areas (AOR = 0.76, 95%CI: 0.61, 0.96), and those living in Bagmati (AOR = 2.16, 95% CI: 1.44, 3.23) and Gandaki (AOR = 2.09, 95%CI: 1.40, 3.14) provinces had higher odds of CCS uptake compared to their urban counterparts and those living in Koshi province, respectively. The odds of CCS increased with age (AOR = 1.06, 95%CI: 1.04, 1.08). Women with secondary education (AOR = 1.47, 95%CI: 1.06, 2.04) had higher odds of CCS uptake compared to those without education. Similarly, married women (AOR = 8.24, 95%CI: 1.03, 66.21), and those with health insurance (AOR = 1.41, 95%CI: 1.08, 1.83) had higher odds of CCS. In conclusion, the uptake of both BCS and CCS was relatively poor among Nepalese women indicating a need for targeted and tailored intervention to increase BCS and CCS uptake.

Introduction

Cancer constitutes a significant public health concern and stands among the top contributors to mortality, responsible for almost 10 million deaths worldwide in 2020 [1]. In the same year, breast cancer affected 2.3 million women, resulting in 685,000 deaths worldwide making it the most prevalent type of cancer [2]. Meanwhile, cervical cancer is ranked as the fourth most common cancer among women on a global scale, with approximately 604,000 new cases and 342,000 deaths reported in 2020. Notably, low- and middle-income countries (LMICs) accounted for about 90% of the deaths caused by cervical cancer observed globally during that year [3].

The age-standardized incidence rate of breast cancer in 2017 was 11.5 per 100000, with a mortality rate of 6.8 per 100,000 women [4]. Similarly, the age-standardized incidence rate of cervical cancer in 2020 was estimated to be approximately 16.4 per 100,000 women, with a mortality rate of 11.1 per 100,000 women [1]. Mortality rates for breast and cervical cancers continue to remain a concern in LMICs particularly due to limited access to comprehensive treatment centers, and lack of awareness among the public.

Breast and cervical cancer screening are crucial strategies in preventing and detecting cancers at early stages. Mammography, clinical breast examination (CBE), and breast self-examination (BSE) are the three commonly used screening tests for breast cancer. Mammography is the recommended standard globally, but for low-resource settings, [5] CBE and BSE are also suggested due to its cost-effectiveness [68]. In Nepal, screening methods for cervical cancer include Papanicolaou (PAP) test, human papilloma virus (HPV) testing, and visual inspection with acetic acid. Early detection of breast and cervical cancers not only save lives but also preserve quality of life and reduces the financial burden associated with advanced-stage cancer treatment [9]. However, delayed detection of breast and cervical cancers remains a common issue, particularly in LMICs like Nepal [10, 11]. A significant proportion of women in these countries seek medical treatment only when the cancer has reached advanced stages [12]. For example, a clinical study in Nepal reported that breast cancer patients often sought treatment at advanced stages, with average tumor sizes ranging from two to five centimeters [13]. This delay results in larger tumors, complicating the treatment and leading to higher mortality rates within Nepal. The lack of universal health coverage adds a significant financial burden on affected individuals and their families [14].

A scoping review states that LMICs including Nepal have inadequate capacity to provide accessible breast and cervical cancer care screening and cancer care. In addition, Nepalese women had low levels of knowledge about breast and cervical cancer, and screening practices for breast and cervical cancer were inadequate among Nepalese women due to sociocultural, geographic, or financial barriers [15]. Supply-side factors contributing to low rates of screening include lack of skilled healthcare personnel, inadequate availability of equipment, challenges in sample transportation, and low number of laboratories with qualified staff. Also, the high cost associated with PAP test in Nepal, makes it unaffordable for the majority of women in Nepal [16].

Nepal’s national guidelines for cervical cancer screening (2010) recommend screening with visual inspection with acetic acid every 5 years for women in the age range of 30–60 years [17]. The goal was set to target at least 50% of women aged 30–60 years in 2010 which was later revised to 70% in 2017 [17]. Though early screening of breast cancer serves as a leading role in reducing the burden of breast cancer mortality, Nepal has no national and regional breast cancer screening program [18]. Additionally, there has been no initiation of population-based breast cancer screening, [19] despite the American Cancer Society recommending that women with an average risk of breast cancer should start annual mammography screening at age 40 [20].

In the context of Nepal, social determinants play a crucial part in awareness and utilization of health services including breast and cervical cancer screening. Various factors limit Nepalese women’s participation in breast cancer screening (BCS) and cervical cancer screening (CCS), including cultural taboos, stigma, low health literacy, financial barriers, geographic challenges, and gender inequality. This is further exacerbated by economic and geographical constraints that make accessing screening services difficult, especially for lower-income individuals and those living in remote areas. Gender disparities also affect women’s autonomy in healthcare decision-making.

Currently, there are limited studies to determine the status of uptake of BCS and CCS among Nepalese women and their associated factors. Thus, this study aimed to determine the status of uptake of BCS and CCS and associated factors among Nepalese women, using the secondary data from Nepal Demographic and Health Survey (NDHS) 2022 [21]. This study contributes to a better understanding of the status of breast and cervical cancer screening uptake in Nepal that can inform policymakers in the development of policies and targeted interventions to improve screening uptake.

Methods

Study design

We analyzed secondary data from NDHS 2022, a nationally representative survey [21].

Study setting

Nepal is a landlocked country located in South Asia occupying an area of 147, 516 km2. The country has seven administrative provinces, consisting of 77 districts, 6 metropolitan cities, 11 sub-metropolitan cities, 276 urban municipalities, and 460 rural municipalities distributed across three ecological belts—mountains, hills, and Terai. Based on Census 2021, the total population of Nepal is 29,164,578 of whom 51.1% are females [22]. Nepal has an overall human development index (HDI) of 0.587 with the HDI of rural and urban settings being 0.647 and 0.561, respectively [23].

Sample size and sampling technique

The sample size and sampling technique of NDHS 2022 is described elsewhere [21]. In brief, the study used implicit stratification with proportional allocation at each lower administrative level to achieve a representative sample. This involved sorting the sampling frame within each stratum before selecting samples based on probability-proportional-to-size at the first stage. In the first stage of sampling, 476 (248 from urban and 228 from rural) primary sampling units (PSUs) were selected with probability proportional to PSU size and with independent selection in each sampling stratum within the sample allocation. A household listing obtained from each selected PSU before the main survey served as the sampling frame for the selection of sample households in the second stage. Thirty households were selected from each cluster, for a total sample size of 14,280 households (7,440 from urban and 6,840 from rural areas). Of the total households selected, interviews were successfully accomplished in 13786 households. A total of 15238 women from 14243 households were eligible, of whom 14845 women were successfully interviewed. Since cervical cancer screening and breast cancer screening are recommended after the age of 30, we only used data of 7,130 women who were aged 30 years and above for analysis.

Data collection

Data collection for NDHS 2022 took place between January 5 and June 22, 2022.

Dependent variables

BCS uptake

The woman was considered to uptake BCS if she reported that a doctor or other health care worker had ever tested her for breast cancer.

CCS uptake

The woman was considered to uptake CCS if she reported that a doctor or other healthcare worker had ever tested her for cervical cancer.

Independent variables

The independent variables were selected based on the literature review and their availability in the NDHS 2022 datasets. The independent variables assessed in this study included ecological belt (mountains, hills, and Terai), place of residence (urban, rural), province (Koshi, Madhesh, Bagmati, Gandaki, Lumbini, Karnali, Sudurpaschim), age (in years), ethnicity (Brahmin or Chhetri, Dalit, Janajati, Madhesi, other), religion (Hindu, non-Hindu), marital status (unmarried, married or living together, divorced or non-living together), wealth quintile (poorest, poorer, middle, richer, richest), education (no education, basic, secondary, higher), occupation (not working, agriculture, professional or technical or manager or clerical, sales and service, skilled or unskilled labor, others), health insurance (covered, not covered), media exposure (present, not present), heard about cervical and breast cancer (yes, no), and heard about cervical and breast cancer screening (yes, no), parity (nullipara, primipara, multipara) and distance to health facility (big problem, not a big problem). The definition of independent variables is present in S1 File.

Statistical analysis

We used R version 4.2.0 [24] and RStudio [25] for data cleaning and statistical analysis. We performed a weighted analysis using the “survey” package [26] to account for the complex survey design of NDHS 2022. Summary statistics for categorical variables were presented using frequency, percent, and 95% CI. Mean and 95% CI were presented to summarize numerical variables. We used univariable and multivariable logistic regression to determine the association of BCS and CCS with independent variables and reported crude odds ratio (COR) and adjusted odds ratio (AOR), and their 95% CI. A p-value of <0.05 was considered statistically significant.

Ethical approval

We received approval from the DHS program to use the NDHS 2022 datasets. NHDS 2022 obtained ethical approval from the institutional review board of ICF International, United States of America (Reference number: 180657.0.001.NP.DHS.01, Date: 28th April 2022) and the ethical review board of Nepal Health Research Council (Reference number: 678, Date: 30th September 2021). Our analysis is based on a publicly available dataset of NDHS 2022. In the survey, written informed consent was obtained from all adult participants.

Results

Table 1 illustrates the key characteristics of the women who participated in the NDHS 2022 survey. The age of the women ranged from 30 to 49 years with the mean age of 38.4 (95%CI: 38.2, 38.5) years. Of total 7,130 women, 41.5% aged 30–40 years and 58.5% aged 40–49 years. Majority of the women resided in urban areas (68.5%). Majority of the women were from the Terai region (53.7%) followed by the hilly regions (40.8%). In terms of the province, most women belonged to Bagmati (22.1%), followed by Madhesh (18.7%), Lumbini (18.2%), and Koshi (16.9%) provinces. In terms of ethnicity, the largest group was Janajati (38.1%), followed by Brahmin/Chhetri (29.6%), Madhesi (14.5%), and Dalit (13.7%). Approximately 93.1% of the women were married, while only 4.9% had attained higher education. Roughly half of the women were engaged in agriculture (56.4%), and around one-fifth were unemployed (16.7%). The women were distributed equally across all wealth quintiles. About half of the women reported exposure to any form of media on a weekly basis, 13.3% had health insurance coverage, and 40.5% perceived distance to health facility as a big problem.

Table 1. Socio-demographic characteristics of Nepalese women aged 30–49 years (n = 7130).

Characteristic All women aged 30–49 years, Women aged
n = 7,130 30–40 years, 40–49 years,
n = 4,169 n = 2,961
Ethnicity    
    Brahmin/Chhetri 2,112 (29.6) 1,207 (29.0) 904 (30.5)
    Dalit 978 (13.7) 596 (14.3) 382 (12.9)
    Janajati 2,719 (38.1) 1,586 (38.0) 1,133 (38.3)
    Madheshi 1,032 (14.5) 600 (14.4) 431 (14.6)
    Others 289 (4.1) 179 (4.3) 110 (3.7)
Religion    
    Hindu 5,961 (83.6) 3,492 (83.8) 2,468 (83.4)
    Non-Hindu 1,169 (16.4) 677 (16.2) 492 (16.6)
Parity      
    Nullipara 306 (4.3) 230 (5.5) 76 (2.6)
    Primipara 910 (12.8) 685 (16.4) 225 (7.6)
    Multipara 5,914 (82.9) 3,254 (78.0) 2,660 (89.9)
Highest educational level      
    No education 3,076 (43.1) 1,364 (32.7) 1,712 (57.8)
    Basic 2,143 (30.1) 1,417 (34.0) 726 (24.5)
    Secondary 1,561 (21.9) 1,102 (26.4) 459 (15.5)
    Higher 350 (4.9) 286 (6.9) 64 (2.1)
Marital status      
    Unmarried 109 (1.5) 78 (1.9) 30 (1.0)
    Married or living together 6,636 (93.1) 3,933 (94.3) 2,703 (91.3)
    Divorced or not living together 385 (5.4) 158 (3.8) 227 (7.7)
Occupation      
    Not working 1,194 (16.7) 729 (17.5) 464 (15.7)
    Agriculture 4,023 (56.4) 2,197 (52.7) 1,826 (61.7)
    Professional/technical/managerial or clerical 536 (7.5) 372 (8.9) 165 (5.6)
    Sales and service 723 (10.1) 450 (10.8) 273 (9.2)
    Skilled or unskilled labor 642 (9.0) 418 (10.0) 225 (7.6)
    Other 12 (0.2) 4 (0.1) 8 (0.3)
Wealth index      
    Poorest 1,189 (16.7) 698 (16.7) 492 (16.6)
    Poorer 1,381 (19.4) 769 (18.4) 612 (20.7)
    Middle 1,439 (20.2) 828 (19.9) 611 (20.6)
    Richer 1,459 (20.5) 903 (21.7) 556 (18.8)
    Richest 1,662 (23.3) 971 (23.3) 690 (23.3)
Place of residence      
    Urban 4,887 (68.5) 2,891 (69.3) 1,996 (67.4)
    Rural 2,243 (31.5) 1,278 (30.7) 965 (32.6)
Ecological region      
    Mountain 399 (5.6) 224 (5.4) 174 (5.9)
    Hill 2,906 (40.8) 1,691 (40.6) 1,215 (41.0)
    Terai 3,826 (53.7) 2,254 (54.1) 1,572 (53.1)
Province      
    Koshi 1,207 (16.9) 689 (16.5) 518 (17.5)
    Madhesh 1,336 (18.7) 775 (18.6) 561 (19.0)
    Bagmati 1,575 (22.1) 922 (22.1) 653 (22.0)
    Gandaki 728 (10.2) 435 (10.4) 294 (9.9)
    Lumbini 1,300 (18.2) 785 (18.8) 515 (17.4)
    Karnali 398 (5.6) 234 (5.6) 164 (5.6)
    Sudurpaschim 585 (8.2) 329 (7.9) 256 (8.6)
Covered by health insurance 948 (13.3) 544 (13.0) 404 (13.6)
Mass media exposure 3,597 (50.4) 2,167 (52.0) 1,429 (48.3)
Distance to Health facility      
    Big problem 2,884 (40.5) 1,567 (37.6) 1,318 (44.5)
    Not a big problem 4,246 (59.5) 2,603 (62.4) 1,643 (55.5)

n: frequency; %: percent; CI: confidence interval

Table 2 presents the awareness of and uptake of breast and cervical cancer screening among Nepalese women stratified by age group. Around three-fourths of the women had heard about breast cancer (77.6%) and cervical cancer (77.0%). Around half of the women had heard about breast cancer screening (52.8%) whereas around one-third (35.3) had heard about the cervical cancer screening. Among women aged 30–40 years and 40–49 years, the uptake of breast cancer screening in their lifetime was 6.0% and 7.1% whereas the uptake of cervical cancer screening was. 9.8% and 13.6% respectively.

Table 2. Heard of breast and cervical cancer and its screening uptake (n = 7,130).

Characteristics 30–49 years women 30–40 years women 40–49 years women
N % (95%CI) n % (95% CI) n % (95% CI)
Heard of Breast cancer 5,535 77.6 (76.0, 79.2) 3,256 78.1 (76.1, 79.9) 2,279 77.0 (75.0, 78.8)
Heard of BCS 3,768 52.8 (50.7, 55.0) 2,247 53.9 (51.4, 56.4) 1,521 51.4 (48.7, 54.0)
BCS uptake 460 6.5 (5.72, 7.29) 249 6.0 (5.12, 6.98) 211 7.1 (5.99, 8.45)
Heard of Cervical Cancer 5,491 77.0 (75.1, 78.8) 3,241 77.7 (75.6, 79.8) 2,251 76 (73.7, 78.2)
Heard of CCS 2,517 35.3 (33.4, 37.3) 1,465 35.1 (32.9, 37.4) 1052 35.5 (33.0, 38.1)
CCS uptake 811 11.4 (10.1, 12.8) 408 9.8 (8.46, 11.3) 403 13.6 (11.8, 15.6)

n: frequency; %: percent; CI: confidence interval; BCS: Breast Cancer Screening; CCS: Cervical Cancer Screening

Among women aged 30 to 49 years and who have heard about breast cancer, 68.1% (95%CI: 66.0, 70.1) had heard about BCS, and out of those who have heard about BCS, 11.0% (95%CI: 9.8, 12.5) had BCS at least once in a lifetime. Moreover, among women aged 30 years and above who have heard about cervical cancer, 45.8% (95%CI: 43.7, 48.0) had heard about CCS, and out of those who have heard about CCS, 26.8% (95%CI: 24.1, 29.7) had CCS at least once in a lifetime.

Among women aged 30–40 years and who have heard about breast cancer, 69.0% (95%CI: 66.6, 71.3) had heard about BCS, and out of those who had heard about BCS, 9.9% (95%CI: 8.6, 11.5) had BCS uptake at least once in their lifetime. Similarly, among women aged 30–40 years and hearing about cervical cancer, 45.2% (95%CI: 42.7, 47.7) had heard about CCS, and out of those who had heard about CCS, 23.0% (95%CI: 20.2, 26.1) had CCS uptake at least once in their lifetime.

Among women aged 40 to 49 years and hearing about breast cancer, 66.7% (95%CI: 64.0, 64.9) had heard about BCS, and out of those who had heard about BCS, 12.8% (95%CI: 10.7, 15.2) had BCS uptake at least once in their lifetime. Similarly, among women aged 40 to 49 years and hearing about cervical cancer, 46.7% (95%CI: 43.8, 49.7) had heard about CCS, and out of those who had heard about CCS, 32.1% (95%CI: 27.9, 36.5) had CCS uptake at least once in their lifetime.

Table 3 presents the association between breast and cervical cancer screening uptake among women aged 30 years and above. In a multivariable logistic regression to determine the association of BCS uptake with socio-demographic variables among women aged 30 years and above, it was observed that women from Terai had 0.54 times less likely to have BCS uptake compared to their counterparts from the mountainous region. The odds of BCS uptake were 2.08 times higher among Dalit women compared to Brahmin/Chhetri women. The odds of BCS uptake were 4% higher for each one-year increase in the age of a woman. The odds of BCS uptake were 1.49, 1.96, and 2.80 times higher in women with basic, secondary, and higher-level education, respectively, compared to women without formal education. Women who had heard about BCS had 6 times higher odds of BCS uptake. The odds of uptake of BCS among women engaged in agriculture was 31% lower compared to unemployed women.

Table 3. Factors associated with BCS and CCS uptake among Nepalese women aged 30 to 49 years.

Characteristics BCS uptake CCS uptake
% (95%CI) COR (95%CI) AOR (95%CI) % (95%CI) COR (95%CI) AOR (95%CI)
Place of residence            
    Urban 7.4 (6.4, 8.6) Ref Ref 13.8 (12.0, 15.7) Ref Ref
    Rural 4.4 (3.7, 5.2) 0.57 (0.45, 0.73)** 1.04 (0.79, 1.37) 6.2 (5.4, 7.1) 0.41 (0.33, 0.52)** 0.76 (0.61, 0.96) *
Ecological region    
    Mountain 6.3 (3.46, 11.2) Ref Ref 9.8 (7.0, 13.5) Ref Ref
    Hill 8.6 (7.22, 10.2) 1.4 (0.72, 2.72) 0.75 (0.50, 1.15) 14.6 (12.6, 17.0) 1.58 (1.05, 2.38)* 1.06 (0.65, 1.73)
    Terai 4.8 (4.03, 5.81) 0.76 (0.39, 1.46) 0.54 (0.31, 0.93)* 9.1 (7.3, 11.2) 0.92 (0.60, 1.42) 0.99 (0.57, 1.73)
Province    
    Koshi 5.1 (3.8, 6.9) Ref Ref 7.3 (5.9, 9.0) Ref Ref
    Madhesh 3.8 (2.7, 5.40) 0.73 (0.45, 1.19) 1.31 (0.73, 2.35) 6.8 (4.5, 10.1) 0.93 (0.56, 1.52) 1.93 (1.08, 3.43)
    Bagmati 10.8 (8.5, 13.6) 2.25 (1.48, 3.40)** 1.3 (0.78, 2.17) 20.5 (16.6, 25.1) 3.29 (2.32, 4.67)** 2.16 (1.44, 3.23)**
    Gandaki 9.4 (7.1, 12.4) 1.92 (1.23, 3.00)* 1.24 (0.73, 2.09) 15.9 (12.9, 19.5) 2.42 (1.73, 3.38)** 2.09 (1.40, 3.14)**
    Lumbini 5.4 (4.0, 7.2) 1.05 (0.68, 1.64) 1.07 (0.69, 1.66) 8.7 (6.3, 11.8) 1.21 (0.80, 1.83) 1.19 (0.81, 1.74)
    Karnali 4.8 (3.6, 6.5) 0.94 (0.60, 1.47) 1.26 (0.75, 2.10) 8.2 (5.9, 11.3) 1.14 (0.75, 1.74) 1.54 (0.96, 2.50)
    Sudurpashchim 3.3 (2.2, 5.0) 0.64 (0.37, 1.08) 0.98 (0.58, 1.67) 8.2 (6.2, 10.8) 1.14 (0.78, 1.67) 1.19 (0.78, 1.82)
Ethnicity    
    Brahmin or Chhetri 8.3 (7.0, 9.9) Ref Ref 17.4 (14.9, 20.2) Ref Ref
    Dalit 6.1 (4.6, 8.1) 0.72 (0.51, 1.01) 2.08 (1.37, 3.16)** 6.9 (5.0, 9.4) 0.35 (0.25, 0.51)** 0.79 (0.52, 1.19)
    Janajati 6.2 (5.0, 7.7) 0.72 (0.53, 0.99)* 1.21 (0.86, 1.70) 10.8 (9.4, 12.5) 0.58 (0.47, 0.71)** 0.78 (0.59, 1.03)
    Madheshi 4.5 (3.1, 6.5) 0.52 (0.33, 0.80)* 1.46 (0.84, 2.53) 7 (5.2, 9.5) 0.36 (0.25, 0.52)** 0.67 (0.42, 1.07)
    Others 3.6 (1.8, 6.8) 0.41 (0.20, 0.83)* 2.54 (1.07, 6.00) 3.5 (1.5, 7.7) 0.17 (0.07, 0.41)** 0.4 (0.15, 1.08)
Religion    
    Hindu 6.7 (5.9, 7.6) Ref Ref 11.7 (10.3, 13.2) Ref Ref
    Non-Hindu 5.3 (4.0, 7.1) 0.79 (0.57, 1.09) 0.82 (0.56, 1.19) 9.8 (7.8, 12.3) 0.82 (0.63, 1.07) 1.14 (0.79, 1.63)
Age (in years)  38.0 (33.2, 44.0) & 1.02 (1.00, 1.04)* 1.04 (1.02, 1.07)**  39.0 (35.0, 44.0) & 1.04 (1.03, 1.06)** 1.06 (1.04, 1.08)**
Wealth index    
    Poorest 2.7 (2.0, 3.5) Ref Ref 5.2 (4.1, 6.5) Ref Ref
    Poorer 4.0 (3.0, 5.4) 1.54 (1.02, 2.33)* 1.36 (0.88, 2.09) 6.0 (4.7, 7.6) 1.16 (0.81, 1.68) 0.96 (0.65, 1.41)
    Middle 4.7 (3.58, 6.1) 1.79 (1.20, 2.67)* 1.46 (0.94, 2.29) 7.3 (5.9, 8.9) 1.44 (1.04, 1.99)* 1.01 (0.68, 1.49)
    Richer 5.8 (4.6, 7.2) 2.25 (1.56, 3.24)** 1.32 (0.80, 2.15) 10 (8.5, 11.8) 2.05 (1.52, 2.76)** 1.08 (0.72, 1.63)
    Richest 13.3 (11.1, 15.9) 5.64 (3.98, 7.99)** 1.69 (0.99, 2.89) 25.1 (21.4, 29.3) 6.16 (4.48, 8.47)** 1.39 (0.87, 2.21)
Education    
    No education 3 (2.4, 3.7) Ref Ref 6 (5.1, 7.1) Ref Ref
    Basic 6.1 (5.0, 7.5) 2.11 (1.51, 2.94)** 1.49 (1.04, 2.13)* 10.2 (8.6, 12.0) 1.76 (1.37, 2.26)** 1.24 (0.92, 1.66)
    Secondary 11.2 (9.3, 13.5) 4.11 (3.05, 5.53)** 1.96 (1.33, 2.88)** 19.8 (16.5, 23.6) 3.84 (2.90, 5.08)** 1.47 (1.06, 2.04)*
    Higher 17.7 (12.8, 23.9) 6.96 (4.46, 10.86)** 2.80 (1.51, 5.19)** 28.1 (21.7, 35.6) 6.08 (4.17, 8.88)** 1.4 (0.77, 2.55)
Marital status    
    Unmarried 7.9 (3.49, 16.7) Ref Ref 2.4 (0.4, 14.6) Ref Ref
    Married or living together 6.5 (5.7, 7.3) 0.81 (0.34, 1.92) 0.61 (0.16, 2.38) 11.9 (10.5, 13.3) 5.51 (0.79, 38.63) 8.24 (1.03, 66.21)*
    Divorced or not living together 5.9 (3.8, 9.2) 0.74 (0.30, 1.86) 0.68 (0.16, 2.86) 5.8 (3.8, 8.9) 2.53 (0.34, 19.01) 3.87 (0.44, 34.18)
Occupation    
    Not working 10.5 (8.3, 13.1) Ref Ref 16.7 (13.3, 20.6) Ref Ref
    Agriculture 3.8 (3.2, 4.6) 0.34 (0.25, 0.47)** 0.59 (0.42, 0.82)* 7.1 (6.1, 8.1) 0.38 (0.28, 0.52)** 0.79 (0.56, 1.10)
    Professional, manager, clerical 13.3 (10.4, 16.8) 1.31 (0.92, 1.85) 0.75 (0.52, 1.08) 25.7 (20.9, 31.2) 1.73 (1.27, 2.35)** 1.05 (0.73, 1.51)
    Sales and service 9.9 (7.4, 13.1) 0.94 (0.64, 1.39) 0.85 (0.58, 1.24) 18 (14.4, 22.3) 1.1 (0.79, 1.53) 1.05 (0.75, 1.46)
    Skilled/unskilled labor 5.7 (3.7, 8.7) 0.52 (0.30, 0.88) 0.63 (0.37, 1.07) 8.7 (6.4, 11.8) 0.47 (0.31, 0.72)** 0.7 (0.43, 1.11)
    Other 8.8 (1.5, 37.5) 0.83 (0.13, 5.19) 0.62 (0.11, 3.57) 31.5 (4.6, 81.5) 2.3 (0.25, 20.91) 1.25 (0.22, 7.13)
Covered by health insurance    
    No 5.7 (4.9, 6.5) Ref Ref 9.9 (8.7, 11.3) Ref Ref
    Yes 11.7 (9.3, 14.7) 2.21 (1.63, 2.99)** 1.32 (0.97, 1.78) 20.8 (17.4, 24.6) 2.37 (1.85, 3.04)** 1.41 (1.08, 1.83)*
Mass media exposure    
    No 4.1 (3.4, 5.0) Ref Ref 7.8 (6.6, 9.2) Ref Ref
    Yes 8.7 (7.6, 10.1) 2.23 (1.73, 2.86)** 1.42 (1.08, 1.86)* 14.9 (13.0, 17.0) 2.06 (1.67, 2.55)** 1.2 (0.95, 1.53)
Heard about BCS or CCS    
    No 1.3 (0.9, 1.8) Ref Ref 3.0 (2.5, 3.6) Ref Ref
    Yes 11.0 (9.8, 12.5) 9.33 (6.47, 13.45)** 6.28 (4.42, 8.92)** 26.8 (24.1, 29.7) 11.96 (9.56, 14.96)** 8.61 (6.84, 10.85)**
Distance to HF    
    Big problem 4.8 (4.1, 5.8) Ref Ref 7.3 (6.23, 8.6) Ref Ref
    Not a big problem 7.6 (6.5, 8.8) 1.6 (1.26, 2.04)** 0.82 (0.62, 1.08) 14.1 (12.3, 16.2) 2.08 (1.67, 2.60)** 0.99 (0.77, 1.28)
Parity    
    Nullipara 5.2 (2.9, 8.9) Ref Ref 9.1 (5.8, 14.0) Ref Ref
    Primipara 9.9 (7.4, 13.2) 2.02 (1.05, 3.92)* 2.64 (1.06, 6.53)* 15.5 (12.4, 19.1) 1.83 (1.07, 3.13)* 1.15 (0.59, 2.23)
    Multipara 6.0 (5.3, 6.8) 1.17 (0.64, 2.13) 2.45 (0.96, 6.25) 10.9 (9.7, 12.2) 1.22 (0.76, 1.97) 1.27 (0.68, 2.37)

* p-value<0.05

** p-value <0.001

& Mean (95% confidence interval)

%: percent; CI: confidence interval; COR: crude odds ratio; AOR: adjusted odds ratio; ref: reference group; BCS: Breast Cancer Screening; CCS: Cervical Cancer Screening

In the multivariable analysis, the odds of CCS uptake were 24% lower in women from rural areas compared to urban areas. The odds of CCS uptake were 2.16 times higher among women from the Bagmati province and 2.09 times higher in Gandaki province, compared to women from the Koshi province. The odds of CCS uptake were 6% higher for each one-year increase in age of a woman. The odds of CCS uptake were 1.47 times higher among women with secondary-level education compared to women without formal education. The uptake was 8.61 times higher among women who had heard about CCS and 1.41 times higher among women with health insurance coverage compared to those who had not heard about CCS and did not have health insurance coverage, respectively.

Discussion

This study assessed the association of socio-demographic factors with the uptake of BCS and CCS among women aged 30 years and above using data from NDHS 2022. Around three-fourths of the women had heard about breast cancer (78%) and cervical cancer (77%). Around half of the total women had heard about breast cancer screening whereas around one-fourth had heard about cervical cancer screening. Provinces, ethnicity, age, education, wealth, marital status, employment, media exposure, and health insurance coverage were identified as key factors associated with the uptake of BCS and CCS.

For CCS uptake, women from urban areas had higher uptake rates compared to rural areas. Women from certain provinces, such as Madhesh, Bagmati, Gandaki, and Karnali, had higher odds of CCS uptake than women from Koshi province. CCS uptake increased with age, education level, awareness of CCS, and health insurance coverage. Regarding BCS uptake, women from the mountain region had higher uptake rates than women from the Terai region. Dalit women showed higher odds of BCS uptake compared to Brahmin/Chhetri women. BCS uptake increased with age, education level, awareness of BCS, and marital status (married and divorced women had higher odds compared to unmarried women). However, women engaged in agriculture had lower odds of BCS uptake compared to unemployed women.

Nepal consists of people from various ethnicities of which Brahmin/Chhetri are regarded as high caste or advantageous group, and Janajati and Dalit as lower or disadvantageous group. Previous studies suggest that women from the Dalit community compared to high caste groups are relatively easy to convince for health-seeking behavior despite their poor financial and social status [15, 27]. This might be the reason for the higher likelihood of BCS uptake among the Dalit group compared to Brahmin women. This could also be because health campaigns often tend to target disadvantaged communities over advantaged ones resulting in increased access and uptake of service among disadvantaged communities.

About 75% of women reported to have heard about breast cancer which falls within the range observed in various regions worldwide. Studies conducted in different countries have reported a wide range of breast cancer awareness among, typically varying from around 40% to 90% [2834]. Awareness levels tend to be higher in more developed countries and regions with robust healthcare systems having access to greater information and better health services. The findings from a study conducted in Nepal demonstrated that around 54.3% women have heard about cervical cancer [35], while in Nigeria, Uganda, and India, several other studies reveal that the percentage of women who possess knowledge about cervical cancer ranged from 65% to 99% [3638]. The relatively low awareness of breast cancer among women identified in our study underscores the urgent need for targeted awareness promotion, particularly among vulnerable and at-risk populations. Improving awareness of breast cancer is crucial in fostering better screening habits and early detection, which are fundamental for enhancing the effectiveness of cancer treatment.

The findings of our study align with previous investigations conducted in Ethiopia, [39] Uganda, [40] and Lesotho [41] which have consistently shown that individuals who had access to media (television or radio) were more likely to be aware of BCS and CCS. This highlights the critical role of media information in improving awareness levels related to breast cancer. To maximize the reach and impact of health education efforts, it is crucial to utilize diverse and multiple channels to disseminate information about breast cancer. Both print and electronic media have proven to be effective tools in health education initiatives [41].

The present study’s findings concerning BCS and CCS uptakes are consistent with prior research, corroborating the importance of knowledge acquisition in influencing screening utilization. The estimated uptake of CCS among women in Ethiopia, as reported by Kassie et al., was found to be 8% [42]. Moreover, their study highlights the significant association between knowledge of cervical cancer and the utilization of CCS [42]. A study examined the uptake of BCS in low-resource Asian countries and reported an overall utilization rate of 19% [43]. This study identified several factors associated with increased BCS uptake, including higher education levels, older age at first birth, female-headed households, access to media communication, and urban residency, in coherence with our study [43]. Similarly, Islam et al. conducted a systematic review, demonstrating that screening practices for both breast and cervical cancers were positively correlated with opportunities for knowledge acquisition [44]. Similar to our study, Islam, et al. also showed that women with higher education levels, urban residency, and employment outside the home exhibited increased screening behaviors [44]. These determinants reflect the complex interplay of sociocultural and economic factors that shape health-seeking behaviors, especially in resource-constrained regions. The findings highlight the importance of designing multifaceted interventions that address both knowledge gaps and socioeconomic barriers to improve breast cancer and cervical cancer screening rates.

Strengths and limitations

This study has several strengths. First, this study is based on the nationally representative survey data so, the results of the study can be generalized for Nepal. Second, this study employed validated questionnaire and trained data enumerators to collect data. Third, we applied weighted analysis to account for non-response and complex survey design. Some limitations linked to this study included a) the directionality of the association of uptake of screening can’t be established due to the cross-sectional nature of this study, b) uptake of BCS and CCS were self-reported which could be affected by recall-bias and social desirability.

Implication to policymakers

In the context of Nepal, enhancing breast cancer screening awareness among women from different socio-demographic strata is pivotal to improving early detection and screening practices. Policymakers should prioritize health promotion interventions that target rural communities, women without formal education, and women from the poorest wealth quintile to raise the uptake of breast and cervical cancer screening. The findings from this study are valuable for clinicians and policymakers engaged in developing strategies for promoting breast and cervical cancer screening uptake.

Conclusion

Though the significant number of women had heard of breast and cervical cancer and their screening, the uptake of BCS and CCS were relatively lower among Nepalese women. The uptake of BCS was associated with ecological belt, occupation, ethnicity, education, and prior information on BCS whereas uptake of CCS was associated with place of residence, province, education, marital status, and enrollment in health insurance. The findings from this study emphasize the need for targeted awareness campaigns, continued efforts in health promotion and education, and comprehensive interventions to address these socio-demographic disparities and improve the awareness and uptake of breast and cervical cancer screenings. By tailoring strategies to address the identified factors, healthcare authorities can effectively increase awareness and uptake of screenings, leading to early detection and improved management of breast and cervical cancer cases.

Supporting information

S1 File. Operational definition of independent variables.

(DOCX)

pgph.0002971.s001.docx (14.9KB, docx)

Acknowledgments

We would like to acknowledge “The DHS Program” for providing us with the dataset for this study. In addition, we would like to acknowledge everybody who have directly or indirectly supported us throughout this study.

Data Availability

The data are publicly available in the official website of The DHS Program (https://dhsprogram.com/data/dataset/Nepal_Standard-DHS_2022.cfm?flag=0).

Funding Statement

The authors received no specific funding for this work.

References

  • 1.Ferlay J, Ervik M, Lam F, Colombet M, Mery L, Piñeros M. Global Cancer Observatory: Cancer Today. Lyon: International Agency for Research on Cancer; Available: https://gco.iarc.fr/today. [Google Scholar]
  • 2.Breast cancer. [cited 23 Jul 2023]. Available: https://www.who.int/news-room/fact-sheets/detail/breast-cancer.
  • 3.Cervical cancer. [cited 23 Jul 2023]. Available: https://www.who.int/news-room/fact-sheets/detail/cervical-cancer.
  • 4.Shrestha G, Thakur RK, Singh R, Mulmi R, Shrestha A, Pradhan PMS. Cancer burden in Nepal, 1990–2017: An analysis of the Global Burden of Disease study. Mahumud RA, editor. PLOS ONE. 2021;16: e0255499. doi: 10.1371/journal.pone.0255499 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 5.Breast Cancer Early Detection and Diagnosis | How To Detect Breast Cancer. [cited 27 Jul 2023]. Available: https://www.cancer.org/cancer/types/breast-cancer/screening-tests-and-early-detection.html.
  • 6.Anderson BO, Yip C-H, Smith RA, Shyyan R, Sener SF, Eniu A, et al. Guideline implementation for breast healthcare in low-income and middle-income countries: overview of the Breast Health Global Initiative Global Summit 2007. Cancer. 2008;113: 2221–2243. doi: 10.1002/cncr.23844 [DOI] [PubMed] [Google Scholar]
  • 7.Provencher L, Hogue JC, Desbiens C, Poirier B, Poirier E, Boudreau D, et al. Is clinical breast examination important for breast cancer detection? Curr Oncol Tor Ont. 2016;23: e332–339. doi: 10.3747/co.23.2881 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 8.Tara S, Agrawal CS, Agrawal A. Validating breast self examination as screening modalities for breast cancer in eastern region of Nepal: a population based study. Kathmandu Univ Med J KUMJ. 2008;6: 89–93. [PubMed] [Google Scholar]
  • 9.World Health Organization. Service Availability and Readiness Assessment (SARA): An annual monitoring system for service delivery: Reference Manual. 2015. Available: https://www.who.int/publications/i/item/WHO-HIS-HSI-2014.5-Rev.1.
  • 10.Singh YP, Sayami P. Management of breast cancer in Nepal. JNMA J Nepal Med Assoc. 2009;48: 252–257. [PubMed] [Google Scholar]
  • 11.Tfayli A, Temraz S, Abou Mrad R, Shamseddine A. Breast cancer in low- and middle-income countries: an emerging and challenging epidemic. J Oncol. 2010;2010: 490631. doi: 10.1155/2010/490631 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 12.Rivera-Franco MM, Leon-Rodriguez E. Delays in Breast Cancer Detection and Treatment in Developing Countries. Breast Cancer Basic Clin Res. 2018;12: 1178223417752677. doi: 10.1177/1178223417752677 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 13.Acharya SC, Jha AK, Manandhar T. Clinical profile of patients presenting with breast cancer in Nepal. Kathmandu Univ Med J KUMJ. 2012;10: 3–7. doi: 10.3126/kumj.v10i3.8009 [DOI] [PubMed] [Google Scholar]
  • 14.Latalski M, Kulik TB, Skórzyńska H, Zołnierczuk-Kieliszek D. [Social consequences of breast cancer in women suffering from the disease]. Wiadomosci Lek Wars Pol 1960. 2001;54: 391–398. [PubMed] [Google Scholar]
  • 15.Rademaker C, Bhandary S, Harder H. Knowledge, awareness, attitudes and screening practices towards breast and cervical cancer among women in Nepal: a scoping review. J Public Health. 2022;30: 1995–2027. doi: 10.1007/s10389-021-01688-7 [DOI] [Google Scholar]
  • 16.Shakya S, Karmacharya BM, Afset JE, Bofin A, Åsvold BO, Syversen U, et al. Community-Based Health Education has Positive Influence on the Attitude to Cervical Cancer Screening among Women in Rural Nepal. J Cancer Educ. 2016;31: 547–553. doi: 10.1007/s13187-015-0863-7 [DOI] [PubMed] [Google Scholar]
  • 17.Narasimhamurthy M, Kafle SU. Cervical cancer in Nepal: Current screening strategies and challenges. Front Public Health. 2022;10: 980899. doi: 10.3389/fpubh.2022.980899 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 18.Giri M, Giri M, Thapa RJ, Upreti B, Pariyar B. Breast Cancer in Nepal: Current status and future directions (Review). Biomed Rep. 2018. [cited 27 Jul 2023]. doi: 10.3892/br.2018.1057 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 19.Giri M, Puri A, Upreti B. Current status of breast cancer in Nepal. Int J Res Med Sci. 2019;7: 2463. doi: 10.18203/2320-6012.ijrms20192547 [DOI] [Google Scholar]
  • 20.ACS Breast Cancer Screening Guidelines. [cited 14 Dec 2023]. Available: https://www.cancer.org/cancer/types/breast-cancer/screening-tests-and-early-detection/american-cancer-society-recommendations-for-the-early-detection-of-breast-cancer.html.
  • 21.Ministry of Health and Population [Nepal], New ERA, ICF. Nepal Demographic and Health Survey 2022. Kathmandu, Nepal: Ministry of Health and Population [Nepal]; 2023.
  • 22.Ministry of Health and Populations [Nepal]- National Statistics Office. National Population and Housing Census 2021: National Report. Kathmandu, Thapathali; Available: https://censusnepal.cbs.gov.np/results/downloads/national.
  • 23.Government of Nepal-National Planning Comission, United Nations Development Programme. Nepal Human Development Report 2020: Beyond Graduation: Productive Transformation and Prosperity. Lalitpur, Nepal; 2020.
  • 24.R Core Team. R: A language and environment for statistical computing. R Foundation for Statistical Computing. Vienna, Austria; 2022. Available: https://www.R-project.org/. [Google Scholar]
  • 25.RStudio Team. RStudio: Integrated Development Environment for R. RStudio, PBC, Boston, MA; 2022. Available: http://www.rstudio.com/. [Google Scholar]
  • 26.Lumley T. survey: analysis of complex survey samples. 2020. [Google Scholar]
  • 27.Thapa N, Maharjan M, Petrini MA, Shah R, Shah S, Maharjan N, et al. Knowledge, attitude, practice and barriers of cervical cancer screening among women living in mid-western rural, Nepal. J Gynecol Oncol. 2018;29. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 28.Osei-Afriyie S, Addae AK, Oppong S, Amu H, Ampofo E, Osei E. Breast cancer awareness, risk factors and screening practices among future health professionals in Ghana: A cross-sectional study. PloS One. 2021;16: e0253373. doi: 10.1371/journal.pone.0253373 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 29.Abdou A, Van Hal G, Dille I. Awareness, attitudes and practices of women in relation to breast cancer in Niger. Heliyon. 2020;6. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 30.Moodley J, Constant D, Mwaka A, Scott S, Walter F. Mapping awareness of breast and cervical cancer risk factors, symptoms and lay beliefs in Uganda and South Africa. PLoS One. 2020;15: e0240788. doi: 10.1371/journal.pone.0240788 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 31.Abeje S, Seme A, Tibelt A. Factors associated with breast cancer screening awareness and practices of women in Addis Ababa, Ethiopia. BMC Womens Health. 2019;19: 1–8. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 32.Mert T. Evaluation of knowledge and practice regarding mammography among a group of Turkish women attending a tertiary hospital. Turk J Surg. 2022;38: 230. doi: 10.47717/turkjsurg.2022.5672 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 33.Somdatta P, Baridalyne N. Awareness of breast cancer in women of an urban resettlement colony. Indian J Cancer. 2008;45: 149–153. doi: 10.4103/0019-509x.44662 [DOI] [PubMed] [Google Scholar]
  • 34.Montazeri A, Vahdaninia M, Harirchi I, Harirchi AM, Sajadian A, Khaleghi F, et al. Breast cancer in Iran: need for greater women awareness of warning signs and effective screening methods. Asia Pac Fam Med. 2008;7: 1–7. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 35.Shrestha IB, Bhusal S, Rajbanshi M, Mali P, Shrestha RB, Singh DR. Awareness of Cervical Cancer, Risk Perception, and Practice of Pap Smear Test among Young Adult Women of Dhulikhel Municipality, Nepal. Singh A, editor. J Cancer Epidemiol. 2023;2023: 1–9. doi: 10.1155/2023/6859054 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 36.Okunowo AA, Daramola ES, Soibi-Harry AP, Ezenwankwo FC, Kuku JO, Okunade KS, et al. Women’s knowledge of cervical cancer and uptake of Pap smear testing and the factors influencing it in a Nigerian tertiary hospital. J Cancer Res Pract. 2018;5: 105–111. [Google Scholar]
  • 37.Mwaka AD, Orach CG, Were EM, Lyratzopoulos G, Wabinga H, Roland M. Awareness of cervical cancer risk factors and symptoms: cross‐sectional community survey in post‐conflict northern Uganda. Health Expect. 2016;19: 854–867. doi: 10.1111/hex.12382 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 38.Bansal AB, Pakhare AP, Kapoor N, Mehrotra R, Kokane AM. Knowledge, attitude, and practices related to cervical cancer among adult women: A hospital-based cross-sectional study. J Nat Sci Biol Med. 2015;6: 324. doi: 10.4103/0976-9668.159993 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 39.Funga ML, Dilebo ZD, Shuramo AG, Bereku T. Assessing breast cancer awareness on reproductive age women in West Badewacho Woreda, Hadiyya Zone, South Ethiopia; Community based cross-sectional study. PloS One. 2022;17: e0270248. doi: 10.1371/journal.pone.0270248 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 40.Atuhairwe C, Amongin D, Agaba E, Mugarura S, Taremwa IM. The effect of knowledge on uptake of breast cancer prevention modalities among women in Kyadondo County, Uganda. BMC Public Health. 2018;18: 279. doi: 10.1186/s12889-018-5183-5 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 41.Afaya A, Japiong M, Konlan KD, Salia SM. Factors associated with awareness of breast cancer among women of reproductive age in Lesotho: a national population-based cross-sectional survey. BMC Public Health. 2023;23: 621. doi: 10.1186/s12889-023-15443-y [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 42.Kassie AM, Abate BB, Kassaw MW, Aragie TG, Geleta BA, Shiferaw WS. Impact of knowledge and attitude on the utilization rate of cervical cancer screening tests among Ethiopian women: A systematic review and meta-analysis. Musa J, editor. PLOS ONE. 2020;15: e0239927. doi: 10.1371/journal.pone.0239927 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 43.Mahumud RA, Gow J, Keramat SA, March S, Dunn J, Alam K, et al. Distribution and predictors associated with the use of breast cancer screening services among women in 14 low-resource countries. BMC Public Health. 2020;20: 1467. doi: 10.1186/s12889-020-09557-w [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 44.Islam RM, Billah B, Hossain MN, Oldroyd J. Barriers to Cervical Cancer and Breast Cancer Screening Uptake in Low-Income and Middle-Income Countries: A Systematic Review. Asian Pac J Cancer Prev. 2017;18. doi: 10.22034/APJCP.2017.18.7.1751 [DOI] [PMC free article] [PubMed] [Google Scholar]
PLOS Glob Public Health. doi: 10.1371/journal.pgph.0002971.r001

Decision Letter 0

Prabhdeep Kaur

15 Nov 2023

PGPH-D-23-01693

Factors associated with uptake of breast and cervical cancer screening among Nepalese women: Evidence from Nepal demographic and health survey 2022

PLOS Global Public Health

Dear Dr. Bipul Lamichhane

Thank you for submitting your manuscript to PLOS Global Public Health. After careful consideration, we feel that it has merit but does not fully meet PLOS Global Public Health’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process.

Please submit your revised manuscript by 14th December, 2023. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at globalpubhealth@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pgph/ and select the 'Submissions Needing Revision' folder to locate your manuscript file.

Please include the following items when submitting your revised manuscript:

  • A rebuttal letter that responds to each point raised by the editor and reviewer(s). You should upload this letter as a separate file labeled 'Response to Reviewers'.

  • A marked-up copy of your manuscript that highlights changes made to the original version. You should upload this as a separate file labeled 'Revised Manuscript with Track Changes'.

  • An unmarked version of your revised paper without tracked changes. You should upload this as a separate file labeled 'Manuscript'.

Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter.

We look forward to receiving your revised manuscript.

Kind regards,

Prabhdeep Kaur, DNB Medicine, MAE (Epidemiology)

Academic Editor

PLOS Global Public Health

Journal Requirements:

Please review your reference list to ensure that it is complete and correct. If you have cited papers that have been retracted, please include the rationale for doing so in the manuscript text, or remove these references and replace them with relevant current references. Any changes to the reference list should be mentioned in the rebuttal letter that accompanies your revised manuscript. If you need to cite a retracted article, indicate the article’s retracted status in the References list and also include a citation and full reference for the retraction notice.

Additional Editor Comments (if provided):

[Note: HTML markup is below. Please do not edit.]

Reviewers' comments:

Reviewer's Responses to Questions

Comments to the Author

1. Does this manuscript meet PLOS Global Public Health’s publication criteria? Is the manuscript technically sound, and do the data support the conclusions? The manuscript must describe methodologically and ethically rigorous research with conclusions that are appropriately drawn based on the data presented.

Reviewer #1: Yes

Reviewer #2: Partly

**********

2. Has the statistical analysis been performed appropriately and rigorously?

Reviewer #1: Yes

Reviewer #2: Yes

**********

3. Have the authors made all data underlying the findings in their manuscript fully available (please refer to the Data Availability Statement at the start of the manuscript PDF file)?

The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception. The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified.

Reviewer #1: Yes

Reviewer #2: Yes

**********

4. Is the manuscript presented in an intelligible fashion and written in standard English?

PLOS Global Public Health does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.

Reviewer #1: Yes

Reviewer #2: Yes

**********

5. Review Comments to the Author

Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters)

Reviewer #1: The survey is an important exercise and a necessary initiative towards common cancer control in never screened population.The study article is comprehensive with a good representative sample size with analysis of relevant demographic variables. The manuscript is well scripted with robust data inputs.

The authors may explain the following:

1.Around one-third of women respondents being less than 20 years of age, has HPV vaccination been included in the questionnaire?

2.Has the authors explored the reason behind dalit women having better attitude towards screening uptake than the socially considered upper class of brahmin/chetri women?

Reviewer #2: Thank you for asking me to review your paper, which I enjoyed reading. My main concern is with the age group of women who are being asked about screening, given that cervical screening is not recommended to commence before age 30 in most settings and breast screening typically at 40-50 years. I think the analysis and interpretation would really benefit from considering this, particularly in relation to reported cancer screening uptake. Are you also able to provide more information about who provides screening services in Nepal and what their capacity is (i.e. if more women want to screen is it possible? Where are these services located? Is it affordable to most people? Is awareness and acceptance the major barrier to screening or is the availability of and access to services also a major issue?)

Intro

Para one

Line one, Fix wording – insert ‘a’ before major and replace ‘the’ with ‘a’ leading. ie Cancers are a major… and a leading cause of death. Last sentence – 90% of which new cases and deaths – from cervical cancer or something else? Specify.

Third paragraph reword ‘Breast and cervical cancers screening is a crucial strategy’ to ‘Breast and cervical cancer screening are crucial strategies….’

Line 6 – save lives not saves lives

Line6/7 ‘preserve quality of life’ not ‘ preserves the quality of life’

Para 4 last line

Reword ‘and can inform policymakers to assist in the development of policies and targeted interventions to improve screening uptake.’

Methods

Second para line 2, consisting of 53

Line 4 – ‘of whom’, not ‘of which’ (same word replacement needed, second last line of sampling section also)

Line 5 typo delete 1 from 148.9 % male

Dependent variables: unclear – do these mean if the woman ever reported that a doctor or HCW had tested her? This is what I assume from the limitations section saying it was self reported. Was there any explanation to participants about what being screened for either of these conditions would entail (eg breast examination or speculum use etc)? How do we know that the responses are valid/likely to indicate that screening occurred?

Results

What age groups are screen eligible in Nepal for each program? Noting that the sample comprises women aged 15-49 years and that the median age is 29, it is worth noting that the general start age for cervical screening per WHO guidelines is 30 and for breast screening in many countries it is 50. So you would not expect most of these women to be screening even if they were aware of the programs and the programs were available. I suggest that the analysis should be redone or at least stratified by those who are age eligible for the programs rather than including younger women? You have documented in your results a very strong association between screening and age as would be expected for programs where younger people should not be screening.

**********

6. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files.

Do you want your identity to be public for this peer review? If you choose “no”, your identity will remain anonymous but your review may still be made public.

For information about this choice, including consent withdrawal, please see our Privacy Policy.

Reviewer #1: Yes: MALLIGA J SUBRAMANIAN

Reviewer #2: Yes: Julia Brotherton

**********

[NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.]

While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org. Please note that Supporting Information files do not need this step.

PLOS Glob Public Health. doi: 10.1371/journal.pgph.0002971.r003

Decision Letter 1

Prabhdeep Kaur

6 Feb 2024

Factors associated with uptake of breast and cervical cancer screening among Nepalese women: Evidence from Nepal Demographic and Health Survey 2022

PGPH-D-23-01693R1

Dear Bipul Lamichhane,

We are pleased to inform you that your manuscript 'Factors associated with uptake of breast and cervical cancer screening among Nepalese women: Evidence from Nepal Demographic and Health Survey 2022' has been provisionally accepted for publication in PLOS Global Public Health.

Before your manuscript can be formally accepted you will need to complete some formatting changes, which you will receive in a follow up email. A member of our team will be in touch with a set of requests.

Please note that your manuscript will not be scheduled for publication until you have made the required changes, so a swift response is appreciated.

IMPORTANT: The editorial review process is now complete. PLOS will only permit corrections to spelling, formatting or significant scientific errors from this point onwards. Requests for major changes, or any which affect the scientific understanding of your work, will cause delays to the publication date of your manuscript.

If your institution or institutions have a press office, please notify them about your upcoming paper to help maximize its impact. If they'll be preparing press materials, please inform our press team as soon as possible -- no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact globalpubhealth@plos.org.

Thank you again for supporting Open Access publishing; we are looking forward to publishing your work in PLOS Global Public Health.

Best regards,

Prabhdeep Kaur, DNB Medicine, MAE (Epidemiology)

Academic Editor

PLOS Global Public Health

***********************************************************

Reviewer Comments (if any, and for reference):

Reviewer's Responses to Questions

Comments to the Author

1. If the authors have adequately addressed your comments raised in a previous round of review and you feel that this manuscript is now acceptable for publication, you may indicate that here to bypass the “Comments to the Author” section, enter your conflict of interest statement in the “Confidential to Editor” section, and submit your "Accept" recommendation.

Reviewer #1: All comments have been addressed

Reviewer #2: (No Response)

**********

2. Does this manuscript meet PLOS Global Public Health’s publication criteria? Is the manuscript technically sound, and do the data support the conclusions? The manuscript must describe methodologically and ethically rigorous research with conclusions that are appropriately drawn based on the data presented.

Reviewer #1: Yes

Reviewer #2: Yes

**********

3. Has the statistical analysis been performed appropriately and rigorously?

Reviewer #1: Yes

Reviewer #2: Yes

**********

4. Have the authors made all data underlying the findings in their manuscript fully available (please refer to the Data Availability Statement at the start of the manuscript PDF file)?

The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception. The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified.

Reviewer #1: Yes

Reviewer #2: Yes

**********

5. Is the manuscript presented in an intelligible fashion and written in standard English?

PLOS Global Public Health does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.

Reviewer #1: Yes

Reviewer #2: Yes

**********

6. Review Comments to the Author

Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters)

Reviewer #1: Abstract: Page 5 Lines 25-27 Women from Mountain or Terrai-who have better uptake of screening? Please clarify. Conflicting report with the results: page 13 first paragraph first 3 lines

Page 6, line 83 recommendation to replace recommend Page 7 Line 89 –rephrase as access to screening , word repeated

Page 7, Line 125 – biomarker specialist? Please clarify

Page 12, Lines 197, 202 CSS Typo To replace CSS with BCS

Page 13, Table 3 Age in years – not shown –incomplete data

Page 15, Discussion: Lines 28-30 –Provide references for the two studies in Nepal that showed around 77% awareness level

Page 16 Policy implication: Lines 84,85 The authors can rephrase the sentence to target all strata of women, since the authors explain that the health campaigns have already increased uptake among disadvantaged population like Dalit women.

Reviewer #2: Thank you for addressing my previous comments and reanalysing for those aged 30 and over only. I note a couple of errors in the redrafting for correction below.

Delete this sentence line 237-8

A total of 4.4% and 6.4% women 238 had breast and cervical cancer screening in lifetime.

Correction line 260-1 (CCS not BCS before 26.8%)

Moreover, among women aged 30 years and above who have heard about cervical

260 cancer, 45.8% (95%CI: 43.7, 48.0) had heard about CCS, and out of those who have heard about BCS,

261 26.8% (95%CI: 24.1, 29.7) had CCS at least once in a lifetime.

Same error lines 263 and 268 where should be BCS not CCS

**********

7. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files.

Do you want your identity to be public for this peer review? If you choose “no”, your identity will remain anonymous but your review may still be made public.

For information about this choice, including consent withdrawal, please see our Privacy Policy.

Reviewer #1: Yes: malliga j subramanian

Reviewer #2: Yes: Julia Brotherton

**********

Associated Data

    This section collects any data citations, data availability statements, or supplementary materials included in this article.

    Supplementary Materials

    S1 File. Operational definition of independent variables.

    (DOCX)

    pgph.0002971.s001.docx (14.9KB, docx)
    Attachment

    Submitted filename: Resposne to reviewers.docx

    pgph.0002971.s002.docx (26.5KB, docx)

    Data Availability Statement

    The data are publicly available in the official website of The DHS Program (https://dhsprogram.com/data/dataset/Nepal_Standard-DHS_2022.cfm?flag=0).


    Articles from PLOS Global Public Health are provided here courtesy of PLOS

    RESOURCES